Dorsey & Whitney Trust CO LLC Reduces Stake in HCA Healthcare, Inc. $HCA

Dorsey & Whitney Trust CO LLC lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 21.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,284 shares of the company’s stock after selling 356 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in HCA Healthcare were worth $492,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in HCA. Cheviot Value Management LLC bought a new stake in HCA Healthcare during the first quarter valued at approximately $26,000. Saudi Central Bank bought a new stake in shares of HCA Healthcare during the 1st quarter valued at $26,000. WPG Advisers LLC purchased a new position in HCA Healthcare during the first quarter valued at $27,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare in the second quarter worth about $27,000. Finally, Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $27,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

NYSE HCA opened at $481.68 on Thursday. The stock has a market capitalization of $109.92 billion, a PE ratio of 18.62, a P/E/G ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $484.31. The business has a 50 day simple moving average of $437.79 and a two-hundred day simple moving average of $399.25.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Analysts Set New Price Targets

Several equities analysts have weighed in on HCA shares. Truist Financial lifted their price target on shares of HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a report on Monday, October 27th. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a research report on Thursday, November 13th. Jefferies Financial Group lifted their target price on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research note on Tuesday, October 28th. Finally, Robert W. Baird increased their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $474.53.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.